Chemestmed and University of Helsinki sign the research agreement „YTHDF small-molecule ligand screening“
26.01.2022
YTHDF proteins are important regulators of the N6-methyladenosine (m6A) modified RNAs and related to multiple diseases and disorders. This research agreement aims to identify the lead compounds for the YTHDF proteins as basis for the development of future pharmaceuticals. Selection of compounds is based on a pre-made virtual screening of a compound library and specifically designed assay for the YTHDF inhibitor activity measurements. The duration of the agreement is 2 years.